R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
Rise Therapeutics LLC
Rise Therapeutics LLC
Hookipa Biotech GmbH
Revolution Medicines, Inc.
Pfizer
Advaxis, Inc.
Center for Biomedical Research, Inc.
Revolution Medicines, Inc.
Becton, Dickinson and Company
Seagen Inc.
Revolution Medicines, Inc.
MultiVir, Inc.
Sesen Bio, Inc.
Sesen Bio, Inc.
Merck KGaA, Darmstadt, Germany
Access Pharmaceuticals, Inc.
AstraZeneca
AstraZeneca